Is CVS Health (CVS) Pricing Look Interesting After Recent 1 Year Share Price Recovery

Simply Wall St.02-28

If you are wondering whether CVS Health is fairly priced or offering value at its recent levels, you are not alone. This article will walk through what the numbers suggest. The stock last closed at US...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2614986062?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","is_english":true,"pubTime":"2026-02-28 04:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614986062","market":"hk","top_or_hot":-1,"title":"Is CVS Health (CVS) Pricing Look Interesting After Recent 1 Year Share Price Recovery","media":"Simply Wall St.","content":"<div>\n<p>If you are wondering whether CVS Health is fairly priced or offering value at its recent levels, you are not alone. This article will walk through what the numbers suggest. The stock last closed at US...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/is-cvs-health-cvs-pricing-look-interesting-after-recent-1-ye\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is CVS Health (CVS) Pricing Look Interesting After Recent 1 Year Share Price Recovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs CVS Health (CVS) Pricing Look Interesting After Recent 1 Year Share Price Recovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-28 04:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/is-cvs-health-cvs-pricing-look-interesting-after-recent-1-ye><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you are wondering whether CVS Health is fairly priced or offering value at its recent levels, you are not alone. This article will walk through what the numbers suggest. The stock last closed at US...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/is-cvs-health-cvs-pricing-look-interesting-after-recent-1-ye\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4550","symbol_name":"红杉资本持仓","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/is-cvs-health-cvs-pricing-look-interesting-after-recent-1-ye","article_id":"2614986062","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/is-cvs-health-cvs-pricing-look-interesting-after-recent-1-ye","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2614986062","pubTimestamp":1772224699,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If you are wondering whether CVS Health is fairly priced or offering value at its recent levels, you are not alone. This article will walk through what the numbers suggest.\nThe stock last closed at US$78.01, with returns of 0.9% over the past 7 days, 8.3% over 30 days, a 2.6% decline year to date, and 25.6% over 1 year. This gives investors a mix of recent momentum and earlier pullbacks to think about.\nRecent news coverage has focused on CVS Health's position as a large integrated healthcare...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4550":"红杉资本持仓","BK4588":"碎股","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4196":"保健护理服务","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU0072461881.USD":"BGF US BASIC VALUE \"A2\" ACC","BK4581":"高盛持仓","CVS.AU":"Cervantes Corp Ltd","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","BK4585":"ETF&股票定投概念","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","BK4504":"桥水持仓","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","CVS":"西维斯健康"},"translate_title":"在最近一年的股价回升后，CVS Health(CVS)的定价看起来有趣吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1,"CVS.AU":1.5,"CVS":1.5},"content_text":"If you are wondering whether CVS Health is fairly priced or offering value at its recent levels, you are not alone. This article will walk through what the numbers suggest. The stock last closed at US$78.01, with returns of 0.9% over the past 7 days, 8.3% over 30 days, a 2.6% decline year to date, and 25.6% over 1 year. This gives investors a mix of recent momentum and earlier pullbacks to think about. Recent news coverage has focused on CVS Health's position as a large integrated healthcare and pharmacy player in the US, including ongoing attention on its retail footprint and health services offerings. Broader headlines around healthcare costs, reimbursement, and regulation also provide context for how investors may be reassessing risk and potential around the stock. On our framework, CVS Health currently scores 3 out of 6 on its valuation checks. Next we will look at what different valuation approaches say about that score, and then finish with a broader way to think about value that goes beyond any single model.  CVS Health delivered 25.6% returns over the last year. See how this stacks up to the rest of the Healthcare industry. AdvertisementApproach 1: CVS Health Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow, or DCF, model estimates what a business could be worth today by projecting its future cash flows and then discounting those back into today’s dollars. For CVS Health, the model used here is a 2 Stage Free Cash Flow to Equity approach. The company’s last twelve months Free Cash Flow is reported at about $7.6b. Analyst and extrapolated projections suggest Free Cash Flow could reach $13.96b by 2030, with a series of annual estimates between 2026 and 2035 that are discounted back to present value. When all of those projected cash flows are added up and discounted, the model arrives at an estimated intrinsic value of US$286.97 per share. Compared with the recent share price of US$78.01, this implies the stock is about 72.8% below that DCF estimate, which indicates a wide gap between price and this particular valuation model. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests CVS Health is undervalued by 72.8%. Track this in your watchlist or portfolio, or discover 54 more high quality undervalued stocks. CVS Discounted Cash Flow as at Feb 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for CVS Health. Approach 2: CVS Health Price vs Earnings For a profitable company like CVS Health, the P/E ratio is a straightforward way to see how much you are paying for each dollar of earnings. Investors usually accept a higher P/E when they expect stronger growth or see lower risk, and a lower P/E when they expect slower growth or higher risk, so there is no single \"right\" number that fits every stock. CVS Health currently trades on a P/E of 56.13x. That sits above both the Healthcare industry average of 23.76x and the peer group average of 19.40x, so on simple comparisons the shares are pricing in more optimistic assumptions or different risk perceptions than those benchmarks. Simply Wall St’s Fair Ratio for CVS Health is 42.71x. This is a proprietary estimate of what the P/E might be given factors such as the company’s earnings growth profile, industry, profit margins, market cap and specific risks. Because it blends these elements, the Fair Ratio can give a more tailored view than just lining CVS Health up against peers or the broad industry, which may have very different characteristics. With the current P/E of 56.13x above the Fair Ratio of 42.71x, the shares screen as overvalued on this measure. Result: OVERVALUED NYSE:CVS P/E Ratio as at Feb 2026 P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies. Upgrade Your Decision Making: Choose your CVS Health Narrative Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, a simple way for you to attach your story about CVS Health to the numbers. You can link your own view of its future revenue, earnings, margins and fair value to a forecast, then compare that fair value to today’s price inside the Simply Wall St Community page, where Narratives are available to millions of investors and update automatically when new earnings or news arrive. One investor might build a Narrative that sees CVS Health as a healthcare platform with a fair value near US$104.01, while another might focus on execution risks and use a fair value closer to US$62.09. Both can clearly see how their story, forecast and valuation line up with the current share price and their own decision about whether the stock looks expensive or offers value. For CVS Health, however, we will make it really easy for you with previews of two leading CVS Health Narratives: These are investor built views that take the same company data you have just seen and turn it into two very different conclusions on value. 🐂 CVS Health Bull Case Fair value: US$104.01 Price vs this fair value: about 25% below the narrative fair value Revenue growth assumption: 18.02%  Views CVS Health as a healthcare operator in transition, where recent restructuring charges, cost pressures, and leadership changes are short term issues around a larger reset of the business model. Highlights the Health Care Benefits segment, including government focused contracts and rising membership, as a key engine for future revenue, with attention on premium revenues and membership scale. Sees the current share price as undervaluing the company relative to its DCF fair value and peer P/E levels, with potential upside if execution on cost control and integration of acquisitions improves profitability.  🐻 CVS Health Bear Case Fair value: US$62.09 Price vs this fair value: about 26% above the narrative fair value Revenue growth assumption: 7%  Accepts that CVS Health’s integrated model across insurance, pharmacy benefits, and provider services has potential, but focuses on execution challenges and softer profit growth prospects compared with some managed care peers. Flags ongoing policy and healthcare reform debates in the US as a recurring source of risk, with the potential for headline driven volatility if proposals that affect reimbursement or coverage move forward. Points to pressures on the retail footprint, with the risk that weaker in store traffic and changing consumer behaviour could weigh on results unless the format and role of physical stores keep evolving.  Together, these Narratives show you how two well informed investors can look at the same CVS Health data, apply different assumptions on growth, risk, and fair value, and end up with very different conclusions on whether the current price looks high or low. The value is in seeing where your own view fits between them, then tracking how the story and the numbers change over time. Curious how numbers become stories that shape markets? Explore Community Narratives Do you think there's more to the story for CVS Health? Head over to our Community to see what others are saying! NYSE:CVS 1-Year Stock Price Chart  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2614986062","isCrawlerRequest":true}